New and future headache devices
Professor Alan Rapoport provides a holistic overview of new and upcoming devices for patients with headache.
Z
n/a
Alan M. Rapoport M.D. serves as an advisor for Allergan, Amgen, Biohaven, Cala Health, Novartis, Satsuma, Teva Pharmaceutical Industries, Theranica, Xoc and Zosano; he is on the speaker bureau of Allergan, Amgen, Biohaven, Lundbeck and Teva Pharmaceutical Industries.